[Survival analysis on HIV-infected children aged 14 years old and younger in China]

H Yin1, Y Ma1, X Yang1

  • 1National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.

Insights

This study found that HIV-infected children in China have a median survival time of over 14 years. Key factors influencing survival include timely antiviral therapy and access to care services.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Human Immunodeficiency Virus (HIV) infection remains a significant global health challenge, particularly for children.
  • Understanding survival trends and influencing factors in pediatric HIV cases is crucial for improving treatment strategies and outcomes in China.

Purpose of the Study:

  • To determine the survival status of HIV-infected children aged 14 years and younger in China.
  • To identify factors associated with survival time in this pediatric population.

Main Methods:

  • A retrospective cohort study utilizing data from China's HIV/AIDS Comprehensive Response Information Management System (CRIMS).
  • Involved 8,029 HIV-infected children.
  • Cox proportional hazard regression model was employed to analyze survival data and identify significant factors.

Main Results:

  • The median survival time was 179.75 months, with 10-year survival probability at 78.63%.
  • Antiretroviral therapy (ART) significantly improved survival (OR 12.81).
  • Factors such as male sex, younger age at diagnosis, receiving ART outside residential areas, living in Northwest China, and lack of healthcare services were associated with increased mortality risk.

Conclusions:

  • HIV-infected children in China demonstrate a substantial median survival time, highlighting progress in management.
  • Initiation of antiviral therapy, female sex, older age at diagnosis, receiving ART within residential areas, residing in Northeast China, and access to care services are protective factors.
  • Targeted interventions addressing regional disparities and ensuring consistent access to ART and healthcare services are vital for improving long-term outcomes.

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
477
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
573
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
309
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
141
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
630
Censoring Survival Data01:09

Censoring Survival Data

Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
437